Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms (Q52184569)
scientific article published on September 1, 1998
Language:
(P31) (Q13442814)
(P304) 2986-2999
(P407) (Q1860)
(P433) 9
(P478) 16
(P577) Tuesday, September 1, 1998
Tuesday, September 1, 1998
(P921) (Q5452194)
(P953) http://intl.jco.org/cgi/content/abstract/16/9/2986
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.1998.16.9.2986
(P1433) (Q400292)
(P1476) "Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms" (language: en)
(P2093) A. M. Senderowicz
D. Headlee
S. F. Stinson
R. M. Lush
N. Kalil
L. Villalba
K. Hill
S. M. Steinberg
W. D. Figg
A. Tompkins
S. G. Arbuck
E. A. Sausville
other details
description scientific article published on September 1, 1998

External Links